Adrian YS Yip

417 total citations
20 papers, 280 citations indexed

About

Adrian YS Yip is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Adrian YS Yip has authored 20 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Adrian YS Yip's work include Breast Cancer Treatment Studies (4 papers), Oral Health Pathology and Treatment (3 papers) and Cancer Treatment and Pharmacology (3 papers). Adrian YS Yip is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Oral Health Pathology and Treatment (3 papers) and Cancer Treatment and Pharmacology (3 papers). Adrian YS Yip collaborates with scholars based in China, Hong Kong and Japan. Adrian YS Yip's co-authors include Louis W.C. Chow, Wings TY Loo, Louis W.C. Chow, Wings T.Y. Loo, Louis WC Chow, Masakazu Toi, Stefan Glück, Qing Liu, Mary Cheung and Wei Wei and has published in prestigious journals such as Journal of Clinical Oncology, Development and Annals of Oncology.

In The Last Decade

Adrian YS Yip

19 papers receiving 276 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian YS Yip China 11 106 71 48 45 35 20 280
Daniela Fortunato Rêgo Brazil 9 130 1.2× 176 2.5× 75 1.6× 16 0.4× 58 1.7× 18 392
C Popescu Romania 9 79 0.7× 59 0.8× 24 0.5× 17 0.4× 15 0.4× 17 330
Brendell Williams United States 4 180 1.7× 139 2.0× 48 1.0× 24 0.5× 134 3.8× 4 447
Bassam Ahmed Almutlaq Saudi Arabia 8 108 1.0× 36 0.5× 41 0.9× 10 0.2× 28 0.8× 18 265
Turki Y. Alhazzazi Saudi Arabia 9 94 0.9× 198 2.8× 63 1.3× 28 0.6× 20 0.6× 18 514
Xuechen Chen Germany 11 216 2.0× 175 2.5× 64 1.3× 32 0.7× 78 2.2× 20 518
Mousumi Majumder India 9 95 0.9× 211 3.0× 59 1.2× 43 1.0× 18 0.5× 17 342
Mahshid Mehdizadeh Iran 10 55 0.5× 99 1.4× 48 1.0× 12 0.3× 35 1.0× 51 308
Nongnit Laytragoon‐Lewin Sweden 11 93 0.9× 125 1.8× 70 1.5× 9 0.2× 32 0.9× 24 385
Sujata Biswas United Kingdom 11 127 1.2× 136 1.9× 40 0.8× 6 0.1× 32 0.9× 19 378

Countries citing papers authored by Adrian YS Yip

Since Specialization
Citations

This map shows the geographic impact of Adrian YS Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian YS Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian YS Yip more than expected).

Fields of papers citing papers by Adrian YS Yip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian YS Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian YS Yip. The network helps show where Adrian YS Yip may publish in the future.

Co-authorship network of co-authors of Adrian YS Yip

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian YS Yip. A scholar is included among the top collaborators of Adrian YS Yip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian YS Yip. Adrian YS Yip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chow, Louis WC, Stewart Y. Tung, Seock‐Ah Im, et al.. (2013). Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II – III invasive breast cancer: the OOTR-N001 study. Expert Opinion on Investigational Drugs. 22(3). 299–307. 17 indexed citations
4.
Tian, Ye, Jinle Li, Liang Hao, et al.. (2013). Association of Cytokines, High Sensitive C-Reactive Protein, VEGF and Beta-Defensin-1 Gene Polymorphisms and Their Protein Expressions with Chronic Periodontitis in the Chinese Population. The International Journal of Biological Markers. 28(1). 100–107. 15 indexed citations
5.
Loo, Wings TY, Qing Liu, Michael C. W. Yip, et al.. (2013). Status of Oral Ulcerative Mucositis and Biomarkers to Monitor Posttraumatic Stress Disorder Effects in Breast Cancer Patients. The International Journal of Biological Markers. 28(2). 168–173. 12 indexed citations
6.
Chow, Louis W.C., et al.. (2013). Acceptable Cardiac Safety Profile of Neoadjuvant 5-Fluorouracil, Epirubicin, Cyclophosphamide and Celecoxib (FEC-C) for Breast Cancer: A Subanalysis of Biomarkers for Cardiac Injury. The International Journal of Biological Markers. 28(1). 32–37. 4 indexed citations
7.
Liu, Qing, Wings TY Loo, Min Wang, et al.. (2013). Comparative Evaluation of Cytokines in Gingival Crevicular Fluid and Saliva of Patients with Aggressive Periodontitis. The International Journal of Biological Markers. 28(1). 108–112. 30 indexed citations
8.
Fu, Jianmin, Jie Zhou, Jian Shi, et al.. (2012). Emodin affects ERCC1 expression in breast cancer cells. Journal of Translational Medicine. 10(S1). S7–S7. 14 indexed citations
9.
Yu, Jianjun, Daqing Zhang, Wings TY Loo, et al.. (2012). Mouse model of plasma cell mastitis. Journal of Translational Medicine. 10(S1). S11–S11. 25 indexed citations
10.
Loo, Wings T.Y., Liang Hao, Min Wang, et al.. (2012). Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. The International Journal of Biological Markers. 27(4). 314–321. 19 indexed citations
11.
Yu, Jianjun, Daqing Zhang, Wings TY Loo, et al.. (2012). Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma. Journal of Translational Medicine. 10(S1). S13–S13. 10 indexed citations
12.
Wei, Wei, et al.. (2012). Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis. Journal of Translational Medicine. 10(S1). S6–S6. 33 indexed citations
13.
Liu, Qing, Min Wang, Wings TY Loo, et al.. (2012). Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors. The International Journal of Biological Markers. 27(4). 322–330. 7 indexed citations
14.
Chow, Louis W.C., et al.. (2012). Prevention of Oncological Diseases: Primary and Secondary Prevention. The International Journal of Biological Markers. 27(4). 337–343. 4 indexed citations
15.
Han, Hyo S., Isildinha M. Reis, Wei Zhao, et al.. (2011). Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer. European Journal of Cancer. 47(17). 2537–2545. 51 indexed citations
16.
Chow, Louis W.C., Adrian YS Yip, William Chu, Wings T.Y. Loo, & Masakazu Toi. (2011). Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trial. The Journal of Steroid Biochemistry and Molecular Biology. 125(1-2). 112–119. 9 indexed citations
17.
18.
Yip, Adrian YS, Wings T.Y. Loo, & Louis W.C. Chow. (2007). Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system – a Phase I minimization clinical trial. Biomedicine & Pharmacotherapy. 61(9). 588–590. 19 indexed citations
19.
Chow, Louis WC, et al.. (2006). The future perspectives of breast cancer therapy. Biomedicine & Pharmacotherapy. 60(6). 259–262. 2 indexed citations
20.
Yip, Adrian YS & Louis WC Chow. (2006). Clinical experience with docetaxel for Chinese breast cancer patients: Hematological toxicity profiles. Breast Cancer. 13(2). 192–196. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Fortunato Rêgo Breakdown of academic impact, for papers by C Popescu Breakdown of academic impact, for papers by Brendell Williams Breakdown of academic impact, for papers by Bassam Ahmed Almutlaq Breakdown of academic impact, for papers by Turki Y. Alhazzazi Breakdown of academic impact, for papers by Xuechen Chen Breakdown of academic impact, for papers by Mousumi Majumder Breakdown of academic impact, for papers by Mahshid Mehdizadeh Breakdown of academic impact, for papers by Nongnit Laytragoon‐Lewin Breakdown of academic impact, for papers by Sujata Biswas
Rankless by CCL
2026